Iron monitoring and supplementation: How do we achieve the best results?

Nephrology Dialysis Transplantation

Volumn 13, Issue SUPPL. 2, 1998, Pages 9-12

  Schaefer, R M ^a   Schaefer, L ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Ferritin; Hypochromic red blood cells; Iron; r HuEPO; Transferrin saturation

Indexed keywords

FERRITIN; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN; TRANSFERRIN;

BONE MARROW; CONFERENCE PAPER; DIET SUPPLEMENTATION; DIETARY INTAKE; ERYTHROPOIESIS; FERRITIN BLOOD LEVEL; FLOW CYTOMETRY; HEMOGLOBIN SYNTHESIS; HUMAN; IRON DEFICIENCY; IRON INTAKE; IRON OVERLOAD; IRON STORAGE; IRON THERAPY; PRIORITY JOURNAL; TRANSFERRIN BLOOD LEVEL;

EID: 0031977233     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/13.suppl_2.9     Document Type: Conference Paper

References (21)

1. Lipschitz DA, Cook JD, Finch CA. A clinical evaluation of serum ferritin as an index of iron stores. New Engl J Med 1974; 290: 1213-1216
2. Allegra V, Mengozzi G, Vasile A. Iron deficiency in maintenance hemodialysis patients: Assessment of diagnosis criteria and of three different iron treatments: Nephron 1991; 57:175-182
3. Boelaert JR, Cantinieaux BF, Hariga CF, Fondu PG. Recombinant erythropoietin reverses polymorphonuclear granulocyte dysfunction in iron-overloaded dialysis patients. Nephrol Dial Transplant 1983; 5: 504-507
4. Flament J, Goldman M, Waterlot Y, Dupont E, Wybran J, Vanherweghem JL. Impairment of phagocyte oxidative metabolism in haemodialyzed patients with iron overload. Clin Nephrol 1986; 25: 227-230
5. Cantinieaux B, Boelaert J, Hariga C, Fondu P. Impaired neutrophil defense against Yersinia enterocolitica in patients with iron overload who are undergoing dialysis. J Lab Clin Med 1988; 111: 524-528
6. Macdougall IC, Mutton RD, Cavill I, Coles GA, Williams JD. Treating renal anaemia with r-HuEPO: practical guidelines and a clinical algorithm. Br Med J 1990; 300: 655-659
7. Hörl WH, Cavill I, Macdougall IC, Schaefer RM, Sunder-Plassmann G. How to diagnose and correct iron deficiency during r-HuEPO therapy - a consensus report. Nephrol Dial Transplant 1996; 11: 246-250
8. Macdougall IC, Cavill I, Hulme B et al. Detection of functional iron deficiency during r-HuEPO treatment: a new approach. Br Med J 1992; 304: 225-226
9. Schaefer RM, Schaefer L. The hypochromic red cell: a new parameter for the monitoring of iron supplementation during r-HuEPO therapy. J Perinat Med 1995; 23: 83-88
10. Fishbane S, Galgano C, Langley RC, Canfiled W, Maeska JK. Reticulocyte hemoglobin content in the evaluation of iron status of hemodialysis patients. Kidney Int 1997; 52: 217-222
11. Hastka J, Laserre JJ, Schwarzbeck A, Hehlmann R, Strauch M. ZnPP als Alternative zu Ferritin bei der Steuerung der Eisensubstitution Erythropoietin-bedürftiger Dialysepatienten. Nieren Hochdruckkrankh 1991; 20: 697-700
12. Braun J, Hammerschmidt M, Schreiber M, Heidler R, Hörl WH. Is ZnPP an indicator of iron deficient erythropoiesis in maintenance hemodialysis patients? Nephrol Dial Transplant 1996; 11: 492-497
13. Baldus M, Salopek S, Müller M et al. Experience with ZnPP as a marker of endogenous iron availability in chronic hemodialysis patients. Nephrol Dial Transplant 1996; 11: 486-491
14. Eschbach JW, Cook JD, Scribner BH, Finch CA. Iron balance in hemodialysis patients. Ann Intern Med 1977; 87: 710-713
15. Hamstra RD, Block MH, Schocket AL. Intravenous iron dextran in clinical medicine. JAMA 1980; 243: 1726-1731
16. Zanen AL, Adriaansen HJ, van Bommel EFH, Posthuma R, de Jong GMT. Oversaturation of transferrin after intravenous ferric gluconate (Ferrlecit) in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 820-824
17. Sunder-Plassmann G, Hörl WH. Safety of intravenous injection of iron saccharate in haemodialysis patients. Nephrol Dial Transplant 1996; 11: 1797-1802
18. Macdougall IC, Tucker B, Thompson J, Tomson CRV, Baker LRI, Raine AEG. A randomized controlled study of iron supplementation in patients treated with erythropoietin. Kidney Int 1996; 50: 1694-1699
19. Silverberg DS, Blum M, Peer G, Kaplan E, Iaina A. Intravenous ferric saccharate as an iron supplement in dialysis patients. Nephron 1996; 72: 413-417
20. Fishbane S, Ungureanu VD, Maeseka JK. The safety of intravenous iron dextran in hemodialysis patients. Am J Kidney Dis 1996; 28: 529-534
21. Macdougall IC, Chandler G, Armstrong A, Breen C, Harchowal J, Cavill I. Characterisation of iron availability from 3 different intravenous iron preparations in dialysis patients. J Am Soc Nephrol 1997; 8: 221A